US Patent Issued to HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE DIRECTION DE LA POLITIQUE INDUSTRIELLE on Feb. 10 for "Bivalent LECA inhibitors targeting biofilm formation of Pseudomonas aeruginosa" (French, German Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,699, issued on Feb. 10, was assigned to HELMHOLTZ-ZENTRUM FUR INFEKTIONSFORSCHUNG GMBH (Braunschweig, Germany) and CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE DIRECTION DE LA POLITIQUE INDUSTRIELLE (Paris).

"Bivalent LECA inhibitors targeting biofilm formation of Pseudomonas aeruginosa" was invented by Alexander Titz (Saarbrucken, Germany), Eva Zahorska (Saarbrucken, Germany), Saverio Minervini (Saarbrucken, Germany), Anne Imberty (Grenoble, France) and Sakonwan Kuhaudomlarp (Grenoble, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to divalent compounds binding to LecA. The compounds are useful to block biofilm ...